CLOV — Clover Health Investments, Corp. stock price, charts and financials

NASDAQ·Healthcare·Medical - Healthcare Plans·USA

Latest market price

4.27

-0.06-1.39%

Overview Short InterestFilings

CLOVQT86Clover Health Investments, Corp.·NASDAQ

Overview Short InterestFilings

4.27-1.39%

Earnings

Down 1.4% — Reported earnings — EPS in line, revenue beat by 5%.

High confidence

Loading chart...

Screen all →

ALHC-7.14%$13.52 OSCR-1.17%$30.38 MOH-1.75%$191.36 CNC+0.49%$64.07 HUM-3.30%$362.16 CI-2.84%$274.05 ELV-1.25%$378.00 CVS-0.90%$104.42

Snapshot

Index	-	P/E	-	EPS (ttm)	-0.11	Insider Own	49.71%	Shs Outstand	518.26M	Perf Week	-1.61%

Market Cap	2.21B	Forward P/E	55.89	EPS next Y	0.08	Insider Trans	-0.42%	Shs Float	408.51M	Perf Month	-15.61%

Enterprise Value	1.88B	PEG	-	EPS next Q	-	Inst Own	-	Short Float	7.04%	Perf Quarter	61.13%

Income	-57.00M	P/S	1.00	EPS this Y	135.21%	Inst Trans	-	Short Ratio	3.71	Perf Half Y	94.09%

Sales	2.21B	P/B	6.47	EPS next Y	97.24%	ROA	-8.16%	Short Interest	28.75M	Perf YTD	81.70%

Book/sh	0.66	P/C	6.65	EPS next 5Y	63.97%	ROE	-17.08%	52W High	5.59 -23.61%	Perf Year	53.60%

Cash/sh	0.64	P/FCF	39.62	EPS past 3/5Y	-	ROIC	-15.76%	52W Low	1.58 170.25%	Perf 3Y	277.88%

Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	20.60% 23.38%	Gross Margin	18.39%	Volatility	4.30% 5.23%	Perf 5Y	-46.96%

Dividend TTM	-	EV/Sales	0.85	EPS Y/Y TTM	-25.28%	Oper. Margin	-2.57%	ATR (14)	0.24	Perf 10Y	-

Dividend Ex-Date	Aug 23, 2021	Quick Ratio	1.33	Sales Y/Y TTM	61.34%	Profit Margin	-2.58%	RSI (14)	44.31	Recom	3.22

Dividend Gr. 3/5Y	-	Current Ratio	1.33	EPS Q/Q	40.00%	SMA20	-4.74%	Beta	2.47	Target Price	5.13

Payout	0.00%	Debt/Eq	0.00	Sales Q/Q	62.12%	SMA50	-6.05%	Rel Volume	0.50	Prev Close	4.33

Employees	724	LT Debt/Eq	0.01	Earnings	Aug 05	SMA200	42.61%	Avg Volume	7.34M	Price	4.27

IPO Date	Jun 12, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	0.93% 4.80%	Net Debt/EBITDA	3.14	Volume	3,646,474	Change	-1.39%

Analyst Ratings

Date	Action	Analyst	Rating	Target
Jul-21-26	Reiterated	Canaccord Genuity	Buy	$4.20 → $5.50
Jun-11-26	Reiterated	UBS	Neutral	$4.75
Jun-04-26	Reiterated	Canaccord Genuity	Buy	$2.50 → $4.20
Oct-21-25	Reiterated	Leerink Partners		$3.00
Dec-17-24	Initiated	Craig-Hallum	Buy	$6.00
Aug-06-24	Reiterated	Canaccord Genuity	Buy	$2.50
Nov-16-22	Reiterated	Citigroup	Neutral	$1.80
Feb-02-22	Upgrade	Cowen & Co.	Underperform → Market Perform
Jan-07-22	Downgrade	Credit Suisse	Neutral → Underperform
Jul-12-21	Downgrade	JP Morgan	Neutral → Underweight

Latest News

Aug-03-26

Aug-03-2607:30AM

Is Clover Health Finally Turning the Corner?247wallst.com

Jul-31-26

Jul-31-2608:21AM

Clover Health's CEO Just Sold 62,711 Shares for Tax Withholding. The Bigger News Comes Next Week.fool.com

Jul-28-26

Jul-28-2604:02PM

'Trump Administration To End Medicare Drug Plan Subsidy; Program That Held Down Premiums Not Renewed For 2027, Resulting In Higher Costs For Some Seniors' - WSJ ExclusiveBenzinga

Jul-22-26

Jul-22-2604:05PM

Clover Health to Participate in Upcoming Canaccord Genuity 46th Annual Growth Conferenceglobenewswire.com

Jul-17-26

Jul-17-2604:49PM

Clover Health says employee accounts accessed in cyber incidentreuters.com

04:35PM

Clover Health Investments Reports Anomalous Login Activity On Information Systems On July 4, 2026; Does Not Expect Material Impact From Incident; Threat Actor Accessed Three Non-Managerial Employee Accounts Via Social Engineering; Accessed Accounts Had Member Data But No Access To Financial Or Claims Systems; Co. Believes Unauthorized Access Was Contained And TerminatedBenzinga

Jul-09-26

Jul-09-2604:05PM

Clover Health to Report Second Quarter 2026 Financial Results on August 5, 2026globenewswire.com

Jul-07-26

Jul-07-2608:30AM

Clinical Excellence in Continuity of Care: Counterpart Assistant (CA) Use Associated With Stronger Performance Across Transitions of Care Measures and Post-Hospitalization Follow-Upglobenewswire.com

Jul-06-26

Jul-06-2608:32PM

Clover Health's CEO Sold Company Shares Worth $1.7 Million. Here's What That Means for Investors.fool.com

10:02AM

Insurer Elevance Seeks Recalculated Medicare Star Rating in LawsuitBenzinga

Jun-27-26

Jun-27-2601:13PM

A Clover Health Director Sold Over 67,000 Company Shares. Here's a Closer Look at the Transaction.fool.com

Jun-18-26

Jun-18-2608:23AM

Cramer Gives Vistra His Blessing, Backs Stryker, Steers Clear Of AI-Exposed FICOBenzinga

Jun-16-26

Jun-16-2604:13PM

Clover Health Investments' Clover Care Services CEO Brady Priest Stepping Down; Co. Integrating Its Home-Care Business With Its Broader Operations; Not Appointing Priest's SuccessorBenzinga

Jun-11-26

Jun-11-2602:02PM

UBS Maintains Neutral on Clover Health Investments, Raises Price Target to $4.75Benzinga

07:32AM

Clover Health Stock Extends Gains After Court Forces CMS to Upgrade Medicare Star RatingBenzinga

Company

Clover Health Investments, Corp. is a U.S.-based firm specializing in Medicare Advantage insurance. The company leverages its proprietary software platform, the Clover Assistant, to provide both Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) health plans for individuals eligible for Medicare. In addition to its insurance operations, Clover Health also engages in non-insurance-related business ventures. The company was established in 2014 and its main office is located in Franklin, Tennessee.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements

DataTimeframe

Line Item (USD, M)	TTM —	FY 2025 12/31/2025	FY 2024 12/31/2024	FY 2023 12/31/2023	FY 2022 12/31/2022	FY 2021 12/31/2021	FY 2020 12/31/2020	FY 2019 12/31/2019	FY 2018 12/31/2018
Total Revenue	2,212	1,924	1,371	1,261	1,097	1,472	673	462	281
Cost of Goods Sold Incl. D&A	1,804	1,568	1,006	1,005	993	1,551	590	450	0
Gross Profit	407	356	365	256	103	-79	83	13	281
Selling, General and Administrative Excl. Other	199	176	409	440	482	446	192	187	187
Research and Development	0	0	0	0	0	0	0	0	0
Other Operating Expense	265	265	2	21	-92	112	-16	9	289
Operating Income	-57	-86	-46	-205	-287	-637	-93	-183	-186
Interest Expense	0	0	0	0	1	17	57	39	0
Unusual Expense	—	—	—	—	—	—	—	—	—
Non-Operating Income (Expense)	0	0	-1	-5	33	66	13	-141	-16
Net Income Before Taxes	-57	-86	-46	-210	-255	-588	-136	-364	-202
Income Taxes	0	0	0	0	0	0	0	0	0
Consolidated Net Income	-57	-86	-43	-213	-340	-588	-136	-364	-202
Net Income From Continuing Operations	-57	-86	-46	-210	-255	-588	-136	-364	-202
Net Income	-57	-86	-43	-213	-340	-588	-136	-364	-202
EPS (Recurring)	-0.11	-0.17	-0.09	-0.45	-0.71	-1.25	-0.23	-0.90	-4.81
EPS (Basic, Before Extraordinaries)	-0.11	-0.17	-0.09	-0.45	-0.71	-1.25	-0.23	-0.90	-4.81
EPS (Diluted)	-0.11	-0.17	-0.09	-0.45	-0.71	-1.25	-0.23	-0.90	-4.81
EBITDA	-55	-84	-45	-208	-252	-570	-79	-324	-16
Other After Tax Adjustments	—	—	—	—	—	—	—	—	—
Stock Option Compensation Expense	—	—	—	—	—	—	—	—	—
Price To Earnings Ratio	—	—	—	—	—	—	—	—	—
Price To Sales Ratio	1.01	0.63	1.13	0.36	0.40	1.19	10.07	—	—
Gross Margin	18.40	18.50	26.62	20.30	9.39	-5.37	12.33	2.81	100.00
Operating Margin	-2.58	-4.47	-3.36	-16.26	-26.16	-43.27	-13.82	-39.61	-66.19
Net Margin	-2.58	-4.47	-3.14	-16.89	-30.99	-39.95	-20.21	-78.79	-71.89
Shares Outstanding	522	517	490	482	476	471	404	404	42
Market Capitalization	2,229	1,215	1,544	459	442	1,752	6,775	—	—
Operating Lease Expense	—	—	—	—	—	—	—	—	—

Unlock full historical data

See years of past statements with Premium.

Unlock with Premium

Insider Trading Volume

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Soares Karen	Chief Legal Officer	Jul 20 '26	Sale	4.51	51,700	233,167	1,505,522	Jul 20
Reynoso Jamie L.	CEO, Medicare Advantage	Jul 17 '26	Sale	4.53	4,839	21,921	2,814,640	Jul 17
THORNTON JOSEPH CLAY	Interim CFO	Jul 15 '26	Sale	4.67	4,630	21,622	1,212,954	Jul 16
Soares Karen	Chief Legal Officer	Jul 15 '26	Sale	4.67	10,519	49,124	1,557,222	Jul 16
Reynoso Jamie L.	CEO, Medicare Advantage	Jul 15 '26	Sale	4.67	13,119	61,266	2,819,479	Jul 16
Wai Conrad	CEO, Counterpart Health	Jul 15 '26	Sale	4.67	24,215	113,084	1,145,699	Jul 16
Toy Andrew	Chief Executive Officer	Jul 15 '26	Sale	4.67	62,711	292,860	9,547,114	Jul 16
Reynoso Jamie L.	CEO, Medicare Advantage	Jul 08 '26	Sale	4.68	2,384	11,157	2,832,598	Jul 09
Reynoso Jamie L.	CEO, Medicare Advantage	Jul 06 '26	Sale	5.26	6,229	32,765	2,834,982	Jul 06
Toy Andrew	Chief Executive Officer	Jul 01 '26	Sale	5.32	313,476	1,667,692	9,609,825	Jul 01
Reynoso Jamie L.	CEO, Medicare Advantage	Jun 17 '26	Sale	4.78	2,360	11,281	2,841,211	Jun 18
OLDAKOWSKI JOSEPH FRANK	VP OF FINANCE AND CONTROLLER	Jun 16 '26	Sale	4.86	12,102	58,816	299,067	Jun 17
Soares Karen	Chief Legal Officer	Jun 15 '26	Sale	4.61	4,681	21,579	1,567,741	Jun 16
Reynoso Jamie L.	CEO, Medicare Advantage	Jun 15 '26	Sale	4.61	6,350	29,274	2,843,571	Jun 16
Reynoso Jamie L.	CEO, Medicare Advantage	Jun 11 '26	Sale	4.91	7,289	35,789	2,849,921	Jun 11

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR

QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.